Home » Topics » BioWorld Science

BioWorld Science
RSS

Barr receives additional generic approval

Jan. 9, 1998

CNS-5161 shows efficacy in phase I trial

Jan. 9, 1998

Company Profile: PolyMASC

Jan. 9, 1998

Vical receives patent protection for lipid-mediated DNA vaccines

Jan. 8, 1998

Phase II results presented for BB-10010

Jan. 8, 1998

Flocor enters phase I for ACS

Jan. 8, 1998

Vasoflux preclinical data presented at major hematology congress

Jan. 8, 1998

Bayer announces copromotion agreement for cerivastatin

Jan. 8, 1998

Efficacy of recombinant hirudin demonstrated in patients with DIC

Jan. 8, 1998

FDA clears Optison

Jan. 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...